Increased serum levels of C-reactive protein and matrix metalloproteinase-9 in obstructive sleep apnea syndrome
- Author:
- No author available
- Journal Title:
- CHINESE MEDICAL JOURNAL
- Issue:
- 17
- DOI:
- No doi available
- Key Word:
- cardiovascular diseases;C-reactive protein;intermittent hypoxia;matrix metalloproteinase;obstructive sleep apnea
Abstract： Background Obstructive sleep apnea syndrome (OSAS), characterized by intermittent hypoxia/reoxygenation (IHR),has been identified as an independent risk factor for cardiovascular diseases (CVD). The CVD biomarkers associated with OSAS have not been thoroughly investigated.Methods Fifty-one men with OSAS recently diagnosed by polysomnography were classified into two groups according to the severity of apnea: moderate to severe OSAS group (n= 28) and mild OSAS group (n= 23). Twenty-five obese men,of comparable age and body mass index (BMI), without OSAS were chosen as control subjects. Serum metabolic variables, C-reactive protein (CRP) and matrix metalloproteinase-9 (MMP-9) were measured. Spearman correlation and regression analysis were performed.Results Serum concentrations of CRP and MMP-9 were significantly higher in 51 OSAS patients than in 25 control subjects. Levels of CRP and MMP-9 were significantly higher in patients with moderate to severe OSAS than in patients with mild OSAS or in obese control subjects. A positive correlation was found between levels of CRP and MMP-9 in OSAS patients. Regression analysis showed that after adjusting for age and BMI, apnea/hypopnea index (AHI) significantly correlated with serum concentrations of CRP and MMP-9 in patients with OSAS.Conclusions AHI, mirroring the frequency of IHR, was a predictor of enhanced circulating CVD biomarkers MMP-9 and CRP. Our data support the theory that IHR contributes to the upregulation of the inflammatory factors in OSAS patients.
- [1]Ramachandran S, Vasan.Biomarkers of cardiovascular disease: molecular basis and practical considerations.[J].2006,113(19).
- [2]Yang G.C-Reactive Protein-Induced Expression of CD40-CD40L and the Effect of Lovastatin and Fenofibrate on It in Human Vascular Endothelial Cells.[J].2004,27(10).
- [3]Gersh BJ,Somers VK,Shamsuzzaman AS.Obstructive sleep apnea: implications for cardiac and vascular disease.[J].2003,290(14).
- [4]Paul M, Ridker.Clinical application of C-reactive protein for cardiovascular disease detection and prevention.[J].2003,107(3).
- [5]Kasasbeh E,Chi DS,Krishnaswamy G.Inflammatory aspects of sleep apnea and their cardiovascular consequences.[J].2006,99(1).
- [6]Takuya Yokoe,Kenji Minoguchi,Hirofumi Matsuo,etc.Elevated Levels of C-Reactive Protein and Interleukin-6 in Patients With Obstructive Sleep Apnea Syndrome Are Decreased by Nasal Continuous Positive Airway Pressure[J].2003,107(8).
- [7]Newman AB,Redline S,Young TB,etc.Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study (see comments)[J].2000,283(14).
- [8]Xu J,Wang S,Chen P,etc.Serum matrix metalloproteinase 9 as a marker for the assessment of severe acute pancreatitis.[J].2006,208(3).
- [9]Allen Burke,Russell Tracy,Frank Kolodgie,etc.Elevated C-Reactive Protein Values and Atherosclerosis in Sudden Coronary DeathAssociation With Different Pathologies[J].2002,105(17).
- [10]Lindahl B,Siegbahn A,Venge P,etc.Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease (see comments)[J].2000,343(16).
- [11]Steven M, Haffner,Andrew S, Greenberg,Wayde M, Weston,etc.Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus.[J].2002,106(6).
- [12]Tanaka A,Watanabe Y,Samson KT,etc.Increased levels and activity of matrix metalloproteinase-9 in obstructive sleep apnea syndrome.[J].2004,170(12).
- [13]Agusti AG,Vicente E,Carrizo SJ,etc.Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study.[J].2005,365(9464).
- [14]Montero I,Paramo JA,Orbe J,etc.C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells: implications for clinical and subclinical atherosclerosis.[J].2006,47(7).
- [15]Nomoto K,Oguchi S,Kanmatsuse K,etc.Involvement of inflammation in acute coronary syndromes assessed by levels of high-sensitivity C-reactive protein, matrix metalloproteinase-9 and soluble vascular-cell adhesion molecule-1.[J].2003,42(5).
- [16]Abe N,Fujiwara T,Matsunaga T,etc.C-reactive protein-induced upregulation of extracellular matrix metalloproteinase inducer in macrophages: inhibitory effect of fluvastatin.[J].2006,78(9).
- [17]Abu Shamsuzzaman,Mikolaj Winnicki,Paola Lanfranchi,etc.Elevated C-Reactive Protein in Patients With Obstructive Sleep Apnea[J].2002,105(21).
- [18]Suzuki YJ,Jain V,Park AM,etc.Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases.[J].2006,40(10).